Russell L. Knoth

JSS Medical Research (India) — India

Medicine · Health Sciences

13h-index620citations52works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epilepsy research and treatment(9), Pharmacological Effects and Toxicity Studies(8), Health Systems, Economic Evaluations, Quality of Life(7), Acute Myeloid Leukemia Research(6), Alcoholism and Thiamine Deficiency(6)

Publications52 total

Outcomes during BTKi treatment for chronic lymphocytic leukemia: Insights from remote therapeutic monitoring
Blood·2025Open Access
Corrigendum to “Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia” [Leuk. Res. (2022) 106946]
Leukemia Research·2024
Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients’ Perspective
Journal of Clinical Medicine·2023· 8 citedOpen Access
Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induction chemotherapy
Future Oncology·2022· 6 citedOpen Access
Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia
Leukemia Research·2022· 5 cited
Healthcare Resource Utilization and Costs in US Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Chemotherapy
Blood·2021
Time and Side-Effect Burden Associated with Red Blood Cell Transfusions in Patients Diagnosed with Transfusion-Dependent β-Thalassemia
Blood·2021
Understanding the Association between Red Blood Cell Transfusion Dependency and Humanistic, Psychosocial, and Psychological Burden in Patients with β-Thalassemia from the Patients' Perspective
Blood·2021
Real‐world analysis of hospitalizations in patients with epilepsy and treated with perampanel
Epilepsia Open·2021· 7 citedOpen Access
Annual Healthcare Resource Utilization and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia
Blood·2020
Real-World Use of Enasidenib in Relapsed or Refractory Acute Myeloid Leukemia Is Associated with Reduced Risk of Disease Progression and Death
Blood·2020· 1 cited
AML-116: Examining Healthcare Resource Utilization (HCRU) and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia (AML)
Clinical Lymphoma Myeloma & Leukemia·2020· 1 cited
The economic burden of caregiving in epilepsy: An estimate based on a survey of US caregivers
Epilepsia·2020· 46 cited
Risk of hospitalization among patients with epilepsy using long versus short half-life adjunctive antiepileptic drugs
Epilepsy & Behavior·2019· 5 citedOpen Access
Observational Study of Clinical Outcomes of Eribulin Mesylate in Metastatic Breast Cancer After Cyclin-Dependent Kinase 4/6 Inhibitor Therapy
Future Oncology·2019· 17 citedOpen Access
2096-P: Real-World Examination of Lorcaserin Treatment in Patients with Type 2 Diabetes, Prediabetes, and Metabolic Syndrome
Diabetes·2019
Inpatient Hospitalization Rates in Patients Diagnosed with Epilepsy and Treated with Perampanel or Lacosamide (P3.5-018)
Neurology·2019
Inpatient Hospitalization Risk In Patients With Epilepsy Before And After Perampanel Treatment (P3.5-022)
Neurology·2019
Risk of Hospitalization in Patients With Uncontrolled Epilepsy Treated with a Long Versus Short Half-Life Adjunctive Antiepileptic Medication (P3.5-002)
Neurology·2019
Hospitalization costs for nausea and vomiting: A savings opportunity.
Journal of Clinical Oncology·2017· 9 cited
page 1 of 3Next →

Frequent Co-authors

Ronda Copher(12), Tanya G. K. Bentley(5), Shaloo Gupta(5), Jiyoon Choi(5), Manoj Malhotra(5), Ali McBride(5), Victor Benassi(5), David Huggar(4), Zhun Cao(4), Craig Lipkin(4), Thomas W. LeBlanc(4), Sharon A. Rabchenuk(3), Joshua T. Cohen(3), Elena B. Elkin(3), Julie Huynh(3), Arnab Mukherjea(3), Thanh H. Neville(3), Matthew Mei(3), Ioana Popescu(3), Jackie Lee(3)